Using the mouse to model human disease: Increasing validity and reproducibility

DMM Disease Models and Mechanisms

Volumn 9, Issue 2, 2016, Pages 101-103

  Justice, Monica J ^a,c   Dhillon, Paraminder ^b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b The Company of Biologists Limited   (United Kingdom)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; DISEASE MODEL; HUMAN; IMMUNE RESPONSE; MICROBIOME; MOUSE; MOUSE MODEL; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; ANIMAL; VALIDATION STUDY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 84957961660     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.024547     Document Type: Review

References (15)

1. Bersell, K., Choudhury, S., Mollova, M., Polizzotti, B. D., Ganapathy, B.,Walsh, S., Wadugu, B., Arab, S. and Kuhn, B. (2013). Moderate and high amounts of tamoxifen in alphaMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis. Model. Mech. 6, 1459-1469.
2. Collins, F. S. and Tabak, L. A. (2014). Policy: NIH plans to enhance reproducibility. Nature 505, 612-613.
3. Fenwick, N., Griffin, G. and Gauthier, C. (2009). The welfare of animals used in science: How the "Three Rs" ethic guides improvements. Can. Vet. J. 50, 523-530.
4. Han, H. J., Allen, C. C., Buchovecky, C. M., Yetman, M. J., Born, H. A., Marin, M. A., Rodgers, S. P., Song, B. J., Lu, H.-C., Justice, M. J. et al. (2012). Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator. J. Neurosci. 32, 10574-10586.
5. Hatzipetros, T., Bogdanik, L. P., Tassinari, V. R., Kidd, J. D., Moreno, A. J., Davis, C., Osborne, M., Austin, A., Vieira, F. G., Lutz, C. et al. (2014). C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 1584, 59-72.
6. Kilkenny, C., Browne,W. J., Cuthill, I. C., Emerson, M. and Altman, D. G. (2010). Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412.
7. Lexow, J., Poggioli, T., Sarathchandra, P., Santini, M. P. and Rosenthal, N. (2013). Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. Dis. Model. Mech. 6, 1470-1476.
8. Nguyen, T. L. A., Vieira-Silva, S., Liston, A. and Raes, J. (2015). How informative is the mouse for human gut microbiota research? Dis. Model. Mech. 8, 1-16.
9. Perrin, S. (2014). Preclinical research: Make mouse studies work. Nature 507, 423-425.
10. Rosenthal, N. and Brown, S. (2007). The mouse ascending: Perspectives for human-disease models. Nat. Cell Biol. 9, 993-999.
11. Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L. et al. (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110, 3507-3512.
12. Simon, M. M., Greenaway, S., White, J. K., Fuchs, H., Gailus-Durner, V., Wells, S., Sorg, T., Wong, K., Bedu, E., Cartwright, E. J. et al. (2013). A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol. 14, R82.
13. Simpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E. and Sharp, J. J. (1997). Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 16, 19-27.
14. Takao, K. and Miyakawa, T. (2015). Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 112, 1167-1172.
15. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. and Baloh, R. H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 106, 18809-18814.